Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy

BACKGROUND: Previously, we had shown that persons infected with human T-cell lymphoma leukemia virus 1 or 2 (HTLV-1 or 2) had an increased prevalence of antibodies to a peptide in the Pol protein of the retrovirus HERV-K10, homologous to a peptide in HTLV gp21 envelope protein. The prevalence rate w...

Descripción completa

Detalles Bibliográficos
Autores principales: Perzova, Raisa, Graziano, Elliot, Sanghi, Swathi, Welch, Caitlin, Benz, Patricia, Abbott, Lynn, Lalone, Danielle, Glaser, Jordan, Loughran, Thomas, Sheremata, William, Poiesz, Bernard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878045/
https://www.ncbi.nlm.nih.gov/pubmed/24365054
http://dx.doi.org/10.1186/1743-422X-10-360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878045/
https://www.ncbi.nlm.nih.gov/pubmed/24365054
http://dx.doi.org/10.1186/1743-422X-10-360

Ejemplares similares